EQL Pharma AB Namn-Aktier o.N.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

75.51%

Market Cap

-

P/E Ratio

128.12

Dividend Yield

0.00 %

Earnings per Share

0.04 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE1.866 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:33:19 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW1.8661.768
PREV. DAY'S PRICE1.832 (07/20)
CHANGE DAY BEFORE
+0.03
1.86 %
52 WEEK HIGH / LOW8.65 (07/29)1.776 (07/20)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.070.130.040.060.22
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
54.1547.85128.1233.368.24
PRICE - BOOK RATIO
6.929.346.02--
PRICE - SALES RATIO
4.655.683.79--
PRICE - CASH FLOW RATIO
--57.87--
Further Key Figures

Master Data

WKN
A12AZY
ISIN
SE0005497732
SYMBOL
7JK
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
EQL PHARMA AB
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-11.07 %
-18.94 %
-63.72 %
-65.37 %
-75.51 %
--
-64.50 %
HIGH2.072.315.096.278.65--6.27
LOW1.781.781.781.781.78--1.78

Dividende

pro Aktie
EQL PHARMA AB does not deliver dividend information

Company profile

EQL Pharma AB engages in the manufacture, development, and distribution of generic and specialty pharmaceutical products. It offers medicines to pharmacies and hospitals in the Nordic region. It operates through the following geographical segments: Sverige, Danmark, Norge, Finland, Övriga Europa, and Utanför Europa. The company was founded by Karin Wehlin and Lars Christer Fedrik Fåhræus on October 19, 2006 and is headquartered in Lund, Sweden.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.